Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting

BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Fengler, Sophie, Kessler, Josef, Timmermann, Lars, Zapf, Alexandra, Elben, Saskia, Wojtecki, Lars, Tucha, Oliver, Kalbe, Elke
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4954721/
https://ncbi.nlm.nih.gov/pubmed/27437705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0159318
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados